Abstract:Background: Dipeptides and their analogs have multiple biological functions, such as bitter taste, angiotensin-converting enzyme (ACE) inhibition, etc. That design and modification of dipeptides guided by theoretical models are of great significance for research and development on drug, especially in discovery and optimization of lead compound, which can reduce the experimental expenditure and improve the hit rate. Methods: We used conventional 3D-QSAR methods, Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA), and Topomer CoMFA to construct Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) models for four catalogues of dipeptides and their derivatives, which were bitter-tasting dipeptides, ACE-inhibitory dipeptides, anti-cryptococcal and anti-microtubule dipeptide derivatives. The CoMFA and CoMSIA models based on a training set were optimized through varying the force fields and their combination. Topomer CoMFA experientially completed identification and alignment of pose of the fragments. Results and Conclusion: We have achieved theoretical 3D-QSAR models with good reliability of prediction for correspondingly novel samples, which had good statistically significance with excellent cross-validated correlation coefficients (Q(2)>0.5) and conventional correlation coefficients (R-2>0.9). The counter maps from the CoMFA and CoMSIA models could provide the direct information about contributions of the force fields for activity, aiding the design and modification of novel bioactive dipeptides and by which relationships between bitter dipeptides with ACE-inhibitory dipeptides were explored briefly and a set of novel anti-cryptococcal dipeptide derivatives with predicted activities were designed. Topomer CoMFA models for bitter dipeptides, ACE-inhibitory dipeptides and anti-cryptococcal dipeptidomimetics were ideal, proved the above results and could provide a tool for virtual screening.

DEVELOPMENT AND APPLICATION OF 3D-QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODEL OF PACLITAXEL ANALOGUES

Studies on the Quantitative Structure-activity Relationships of Paclitaxel Analogues

The QSAR research of paclitaxel analogues

Study on the Quantitative Structure-Activity Relationships of 10-Oac -Paclitaxel Analogues

The QSAR Research of Taxoids Compounds

Three-dimensional Quantitative Structure–activity Relationship Study on Paullones As CDK Inhibitors Using CoMSIA and CoMFA

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

CoMFA 3D-QSAR Analysis of Epothilones Based on Docking Conformation and Alignment

NEURAL NETWORK PATTERN RECOGNITION STUDY ON THE QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS OF TAXOL ANALOGUE ANTI-TUMOR DRUGS

Theoretical Study On The Reactive Sites And Intramolecular Interactions In Taxol And Its Four Analogues

Combined Pharmacophore Modeling, Docking, And 3d-Qsar Studies Of Plk1 Inhibitors

QSAR Study of Podophyllotoxin Derivatives As Potential Antitumor Drugs

Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures.

3D-QSAR and Docking Studies of Piperidine Carboxamide Derivatives As ALK Inhibitors

Molecular-docking-guided design, palladium-catalyzed synthesis and anticancer activity of paclitaxel-benzoxazoles hybrids

Medicinal Chemistry of Paclitaxel and Its Analogues

3D-QSAR Analysis on ATR Protein Kinase Inhibitors Using CoMFA and CoMSIA.

3D-QSAR Study of AHMA Derivatives as Potent Anticancer Agents

Research Progress in the Quantitative Structure-Antitumor Activity Relationship Studies of Taxol Derivatives

Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity

Theoretical Modeling and Systemic Analysis of Various Active Dipeptides and Analogues with 3D-QSAR Methods